-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $125

Benzinga·10/22/2026 10:06:02
BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $134 to $125.